Engaging Pharmacists to Advance Tobacco Treatment Service Delivery for People Living With HIV
试验速览
- 阶段
- 不适用
- 状态
- Enrolling By Invitation
- 入组人数
- 172
- 试验地点
- 1
- 主要终点
- Adoption of the Intervention
研究概览
简要总结
This research will test the effects of a novel program (ENHANCE-TTS) with tools, training, and clinic facilitation support that capitalizes on pharmacists' roles by expanding their scope of practice to deliver tobacco treatment. This effectiveness-implementation study will evaluate the effects of the ENHANCE-TTS program on implementation outcomes and patient-level smoking cessation outcomes in people living with HIV and concurrently identify key barriers and facilitators to implementing this program in practice.
详细描述
The overall goal of this research is to improve care for people living with HIV through the delivery of high-quality tobacco treatment to address the high rates of smoking in this population. This research will test the effects of a novel program on pharmacists' roles by expanding their scope of practice to deliver tobacco treatment. Investigators will evaluate provider- and patient-level outcomes.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Sequential
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 21 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Pharmacist, Clinic Administrator, and Patient Advocate inclusion criteria:
- •Pharmacists, Clinic Administrators, and Patient Advocates from each of 6 Ryan White clinics who agree to participate in the study.
- •Clinic patient inclusion criteria:
- •age 21 and older
- •current diagnosis of HIV
- •completed at least 1 visit with the clinical pharmacist for tobacco treatment, 4) English speaking;
排除标准
- •1) currently imprisoned.
研究组 & 干预措施
ENgaging pHarmacists to AdvANCE Tobacco Treatment Service delivery (ENHANCE-TTS)
The ENHANCE-TTS program includes team-building at each clinic, pharmacist training, facilitation (i.e., infrastructure planning for systems change, problem-solving, and coaching) and tools (clinic roadmap, readiness assessment, training workbook).
干预措施: ENgaging pHarmacists to AdvANCE Tobacco Treatment Service delivery (ENHANCE-TTS) (Behavioral)
结局指标
主要结局
Adoption of the Intervention
时间窗: From baseline clinic engagement to 12 months following program launch
Adoption is characterized as pharmacists' tobacco treatment care delivery adoption (comparing pre-implementation to post-implementation rates of tobacco use disorder diagnosis codes entered, tobacco treatment pharmacotherapy prescriptions written \[e.g., varenicline\], and tobacco treatment counseling codes entered).
Acceptability of the Intervention
时间窗: 3-Month Implementation Period
We will measure acceptability at the provider level via the 4-item Acceptability of Intervention Measure (AIM) and a training satisfaction survey.
Fidelity to the Intervention
时间窗: Implementation Period Through Study Completion (approximately 4 year study period)
Fidelity at the clinic level is defined as the percentage of total program launch and implementation steps completed (i.e., kick-off, infrastructure build, training, coaching calls and systems change). Fidelity at the provider level is defined as the percentage of assessment and counseling steps completed (assessment of smoking history and current dependence, environmental triggers for smoking, pharmacotherapy options, and behavioral strategies for coping with urges to smoke).
Cost to Implement the Intervention
时间窗: 3-Month Implementation Period
Cost is defined as costs to deliver the intervention (e.g., the sum of the costs of the TTS training, travel, hours of consultation participation and number of staff included, training and technical assistance).
Penetration of the Intervention
时间窗: From Study Start (Pre-Implementation Period) to Study Completion (Post-Implementation Period) (approximately 4 year study period)
Penetration of the intervention is defined as the total number of counseling appointments delivered over the total number of smoking patients and the pace of completed counseling appointments over the Implementation period compared to the Pre-Implementation period.
次要结局
- Smoking Abstinence(3- and 6-month follow-up)
研究者
Alana Rojewski
Associate Professor-Faculty
Medical University of South Carolina